Virax Biolabs Group Ltd
VRAXNasdaq
$3.79
↓ -2.8%Jul 17 close · end-of-day
Price
1Y↓ -83.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Virax Cayman is a holding company incorporated as an exempted company under the laws of the Cayman Islands. As a holding company with no material operations of our own, Virax Cayman conducts our operations through its operating subsidiaries in Singapore, Hong Kong, China and British Virgin Islands and has been operating since 2013. Our principal executive office is located at 30 Broadwick Street London, W1F 8LX, United Kingdom. Our telephone number is +44 020 7788 7414. Our registered office in the Cayman Islands is located at the office of Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands. Our agent for service of process in the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY.
- CEO
- James Foster
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 5
- Website
- viraxbiolabs.com
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jul 13, 2026
Jul 9, 2026
- 11d agoVirax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceedsfinance.yahoo.com
- 11d agoWhy Did Virax Biolabs Stock Triple In One Session?finance.yahoo.com
- 11d agoVirax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX)investorshub.advfn.com
- 11d agoVirax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnosticsfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.